Skip to main content
Depressors Pill News
COVID-19 Updates
News

COVID-19 Updates: October 13th, 2023

On September 11th, 2023, the U.S. Food and Drug Administration approved and authorized the emergency use of an updated COVID-19 vaccine formulated to closely target circulating variants and to provide better protection against serious consequences of COVID-19.

Per the FDA’s website, here is a summary of recommended vaccination schedules based on your age group and previous vaccination status:

  • Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA COVID-19 vaccine at least 2 months since the last dose of any COVID-19 vaccine.
  • Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of an updated mRNA COVID-19 vaccine (timing and number of doses to administer depends on the previous COVID-19 vaccine received).
  • Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated authorized Moderna COVID-19 Vaccine.

For more information regarding COVID-19 and the updated vaccine, please visit the below resources:

To read previous COVID-19 Maxor updates, click here.

Maxor
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.